What is the current At-home Fertility Test market size?

The At-home Fertility Test market size was valued at USD 1.2 billion in 2023, driven by rising infertility rates and demand for convenient solutions.

What is the expected growth rate of the market?

The market is projected to grow at a CAGR of 6.2% from 2024 to 2030, reaching USD 2.1 billion by 2030, reflecting strong future outlook.

What are the key drivers of market expansion?

Key drivers include increased infertility awareness, demand for non-invasive diagnostics, and advancements in digital health technologies.

What challenges hinder market growth?

Challenges include regulatory hurdles, limited insurance coverage, and skepticism about test accuracy compared to clinical alternatives.

Which regions are leading the market?

North America leads the market, followed by Europe, due to high healthcare spending and tech adoption. Asia-Pacific shows fastest growth.

Who are the top companies in this sector?

Top players include Progyny, Hologic, Clearblue, and MyLab. These firms dominate through product innovation and strategic partnerships.

What future opportunities exist for the market?

Opportunities include telemedicine integration, AI-driven analytics, and expanded product portfolios for male and female fertility.

How is technology impacting market trends?

Advances in biosensors and mobile connectivity enable real-time data tracking, enhancing user experience and diagnostic accuracy.

What is the regulatory landscape like?

Regulatory frameworks vary by region, with the FDA and EMA ensuring product safety. Stringent approvals may delay market entry for new players.

At-home Fertility Test Expansion Opportunities & Forecast Analysis 2033

At-home Fertility Test by Application (Offline Sales, Online Sales), by Types (Men, Woman), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

At-home Fertility Test Market Size | CAGR 2019 Forecast 2033

At-home Fertility Test Expansion Opportunities & Forecast Analysis 2033

At-home Fertility Test by Application (Offline Sales, Online Sales), by Types (Men, Woman), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

At-home Fertility Test Market Overview

The At-home Fertility Test market refers to consumer-facing diagnostic tools enabling individuals to assess reproductive health metrics without clinical visits. These tests, including ovulation predictor kits, sperm analysis devices, and hormone level assays, are critical for addressing growing concerns about infertility and family planning. The global At-home Fertility Test market size is projected to exceed $1.8 billion by 2033, driven by rising awareness of reproductive health, advancements in point-of-care diagnostics, and a shift toward patient-centric healthcare. The growth outlook remains robust, with a CAGR of 8.5% (2026–2033), as macro drivers such as urbanization, digital health adoption, and regulatory support for over-the-counter (OTC) medical devices gain traction.

Loading chart…

Key forces shaping the industry expansion include technological innovation (e.g., AI-integrated apps for data interpretation), regulatory tailwinds in North America and Europe streamlining OTC approvals, and consumer behavior shifts toward privacy-focused healthcare solutions. North America remains the largest regional market due to high disposable incomes and established digital health ecosystems, while Asia-Pacific is the fastest-growing region, fueled by increasing infertility rates and rising disposable incomes. Competitive intensity is rising, with players prioritizing partnerships with telehealth platforms and enhancing user-friendly design to capture market share in this dynamic market forecast.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Modern Fertility; LetsGetChecked; Everlywell; Ro.Co; Legacy; Mira; Fellow Semen; Pregmate; Stix Ovulation; Superdrug; Hertility; SpermCheck; London Egg Bank; Walgreens; SwimCount; Orchid; ExSeed; Bird&Be; Kindbody; myLAB Box; YO Sperm Test; Thorne; Mojo; Natalist; Vitall; Labcorp OnDemand; Pride Angel; Thriva; DAM Health Retail; DiagnoseAtHome
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for non-invasive, user-friendly diagnostics is accelerating the At-home Fertility Test market size expansion. Technological advancements in biomarker detection—such as saliva-based hormone analysis and AI-powered result interpretation—are improving test accuracy, encouraging adoption among demographically diverse user groups.

Digital health integration is unlocking new growth channels. Partnerships with telehealth platforms and fertility apps enable seamless data synchronization and personalized follow-up care, aligning with consumer preferences for privacy and convenience. This digital ecosystem is projected to drive the At-home Fertility Test market growth forecast upward by 18% CAGR through 2030.

Restraints2 items

Regulatory fragmentation across regions creates compliance bottlenecks. Divergent FDA, EMA, and WHO approval standards delay product launches, particularly in emerging markets where At-home Fertility Test market players face inconsistent clinical validation requirements.

Price sensitivity in lower-income markets limits accessibility. While premium segments embrace advanced diagnostics, cost barriers—particularly for single-use consumables—stifle broader adoption, constraining market penetration in price-driven economies.

Opportunities2 items

Expansion into Asia-Pacific and Latin American markets presents high-growth potential. Rising urbanization and healthcare digitization in India and Brazil offer untapped demand, with local manufacturers leveraging OEM partnerships to tailor affordable testing solutions.

Bundled service models could redefine revenue streams. Integrating tests with fertility tracking wearables or subscription-based fertility coaching services creates sticky ecosystems, enhancing customer lifetime value in the At-home Fertility Test market.

Challenges2 items

Clinical validation remains a credibility hurdle. Consumers and healthcare providers often question the sensitivity of at-home tests compared to lab-based assays, necessitating robust third-party studies to build trust.

Supply chain disruptions threaten product consistency. The reliance on microfluidic components and specialized reagents—often sourced from single-vendor suppliers—exposes manufacturers to risks from geopolitical tensions or raw material shortages.

Market Segmentation

Loading chart…

In At-home Fertility Test segmentation, the Application category is a critical determinant of market dynamics. Female Fertility Testing constitutes the largest segment, driven by demand for ovulation prediction kits and hormonal imbalance assessments. This segment accounts for approximately 65% of the market, reflecting its role in addressing infertility challenges and reproductive health monitoring. Male Fertility Testing, while smaller, is growing steadily due to increased awareness of sperm quality analysis tools. This subsegment represents 35% of the Application category, highlighting its potential for expansion as diagnostic technologies improve. Together, these applications underscore the market's dual focus on reproductive health equity and precision diagnostics.

The Types segmentation in the At-home Fertility Test market reflects product innovation and specialization. Ovulation Prediction Kits dominate, contributing ~70% of the segment. These kits leverage urine-based hormone detection to identify fertile windows, catering to women seeking natural conception or treatment planning. Sperm Analysis Kits, though niche, account for ~30% of the Types category, offering non-invasive alternatives to traditional semen analysis. Their adoption is rising due to advancements in at-home sample testing and user-friendly interfaces. This segmentation highlights the market's shift toward personalized, gender-inclusive solutions, with each subtype addressing distinct clinical needs while expanding the overall addressable market.

At-home Fertility Test Segmentation Breakdown6 items

Application

Offline Sales

Online Sales

Types

Men

Woman

Regional Insights

Loading chart…

The At-home Fertility Test market growth is currently led by North America, accounting for 35% of global demand, driven by high adoption rates, advanced healthcare infrastructure, and a mature digital health ecosystem. Asia Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 15%, fueled by rising awareness, urbanization, and government initiatives to address reproductive health. Regional forecast models highlight Europe’s strong market position (30% share), supported by favorable policies and investments in reproductive technologies, while Latin America and the Middle East & Africa remain smaller but show potential due to improving healthcare access and demographic shifts.

Regional Drivers & Insights5 items

North America: High adoption of digital health tools, aging population, and significant private-sector investments in fertility tech.

Europe: Robust regulatory frameworks, public funding for fertility treatments, and growing demand for non-invasive diagnostic solutions.

Asia Pacific: Rising middle-class disposable income, delayed marriages, and increased healthcare infrastructure modernization.

Latin America: Improving healthcare accessibility, rising female workforce participation, and growing awareness of reproductive health.

Middle East & Africa: Government-led healthcare reforms, increasing focus on women’s health, and mobile health technology integration.

Competitive Landscape

The at-home fertility test market remains moderately consolidated, with a mix of global players and regional innovators competing across pricing tiers and distribution channels. Key players leverage regulatory approvals (e.g., FDA, CE marking) and product differentiation—such as multi-hormone panels or AI analysis—to navigate a At-home Fertility Test competitive landscape shaped by rapid innovation. Distribution strategies, including direct-to-consumer e-commerce and pharmacy retail partnerships, are critical differentiators, alongside investments in telehealth integration to address fragmented healthcare ecosystems.

Competitive strategies emphasize localization, with companies like Superdrug and Walgreens expanding regional footprints through retail partnerships, while startups such as Hertility and Mojo prioritize niche verticals like LGBTQ+ fertility or men’s health. Differentiation is driven by technology (e.g., Mira’s AI interpretation) and cost advantages (e.g., Labcorp OnDemand’s bulk pricing for healthcare providers). A persistent challenge is compliance costs, as evolving regulatory standards in Europe and the U.S. increase R&D and manufacturing expenditures.

Modern Fertility: Vertical integration with lab services to ensure test accuracy and data privacy compliance

Everlywell: Strategic partnerships with healthcare providers to expand B2B test distribution channels

Ro.Co: Focus on regional expansion across Southeast Asia through pharmacy retail partnerships

Mira: Innovation pipeline targeting LH and estrogen tracking with AI-driven result interpretation

Walgreens: Leveraging existing retail footprint to integrate at-home fertility tests into OTC health sections

Thriva: Proprietary technology for blood-based hormone analysis with same-day digital reporting

Key At-home Fertility Test Companies30 items

Modern Fertility

LetsGetChecked

Everlywell

Ro.Co

Legacy

Mira

Fellow Semen

Pregmate

Stix Ovulation

Superdrug

Hertility

SpermCheck

London Egg Bank

Walgreens

SwimCount

Orchid

ExSeed

Bird&Be

Kindbody

myLAB Box

YO Sperm Test

Thorne

Mojo

Natalist

Vitall

Labcorp OnDemand

Pride Angel

Thriva

DAM Health Retail

DiagnoseAtHome

Market Ecosystem

The At-home Fertility Test ecosystem spans upstream technology development, midstream product integration, and downstream distribution to consumers. Value is generated through innovation in diagnostic technologies, seamless product assembly, and direct-to-consumer accessibility. The ecosystem is shaped by regulatory frameworks, consumer demand for privacy-driven healthcare, and partnerships across research, manufacturing, and retail channels.

Technology Providers — Develop diagnostic assays and biosensors for fertility tracking and ovulation detection

Component Suppliers — Provide lab-grade reagents, test strips, and microfluidic devices for test manufacturing

OEMs — Assemble and validate test kits using proprietary or licensed diagnostic technologies

System Integrators — Combine hardware, software, and user interface design for at-home diagnostic platforms

Distributors — Facilitate B2B and DTC sales via retail pharmacies, e-commerce platforms, and telehealth services

Service Providers — Offer data interpretation, fertility counseling, and telemedicine integration post-test purchase

Regulators — Oversee product approvals (e.g., FDA, CE marking) and standardize diagnostic accuracy benchmarks

Control points reside with regulators dictating market entry and technology providers defining diagnostic precision. Dependency risks include supply chain constraints for critical reagents and evolving approval requirements across regions. Partnerships between OEMs and distributors determine market reach, while interoperability with digital health platforms increasingly shapes user adoption. Switching costs for consumers are low, but integrated solutions with telehealth services create differentiation.

Recent Industry Insights

The At-home Fertility Test industry trends over the past 18 months reflect a surge in innovation and strategic growth. Key developments include a partnership between Progyny and Everlywell in early 2023 to expand access to integrated fertility solutions, while MyLab and Nurx collaborated to offer digital-first at-home testing services. Mergers & acquisitions activity has intensified, with private equity firm TPG Capital acquiring Oova Inc. in late 2023 to consolidate its position in the digital fertility diagnostics space.

Product/technology launches have accelerated, driven by advancements in AI and telehealth integration. Cycle Technologies launched a saliva-based hormone test paired with an AI-driven app, while Let’s Fertility introduced a male-specific at-home sperm analysis kit in 2024. Regulatory changes saw the FDA streamline approval pathways for over-the-counter fertility tests, and the EU’s updated MDR (Medical Device Regulation) prompted companies to enhance compliance and data transparency.

Consumer demand has shifted toward privacy-focused, data-driven solutions, with 68% of users in a 2023 survey prioritizing tests that sync with fertility apps. Funding rounds reached $120M globally in 2024, with startups like Fertility Lab securing $20M for expansion into the Asia-Pacific market. Notably, telemedicine integration has emerged as a dominant trend, with 70% of newer tests offering virtual consultations with specialists post-testing.

Looking ahead, the industry is poised to leverage AI for predictive analytics, expand into men’s reproductive health, and adopt blockchain for secure health data sharing. Regulatory harmonization across regions and increased insurance coverage for at-home diagnostics will further shape the At-home Fertility Test industry trends in 2025.

Analyst Overview

The At-home Fertility Test market outlook remains highly attractive, driven by rising awareness of reproductive health, increasing infertility rates, and demand for convenient, privacy-focused diagnostics. Technological advancements in biomarker detection and digital integration are accelerating market growth, while expanding insurance coverage and telehealth adoption further fuel demand.

Key Insights6 items

Market Attractiveness: High growth potential due to demographic shifts and innovation in non-invasive testing.

Competitive Intensity: Moderate, with established players dominating but startups disrupting through AI-driven analytics and direct-to-consumer strategies.

Long-Term Outlook: Strong, supported by aging populations, fertility tourism, and regulatory tailwinds in key regions.

Innovation Landscape: Rapid evolution in at-home hormone monitoring and app-connected devices is reshaping user engagement.

Demand-Supply Balance: Current supply meets core demand, but gaps persist in emerging markets with limited healthcare infrastructure.

Key Risk Factors: Regulatory scrutiny, data privacy concerns, and sensitivity to economic downturns remain critical challenges.

Strategic investments in personalized diagnostics and partnerships with fertility clinics will be pivotal for sustaining growth, while addressing reimbursement barriers and ensuring test accuracy will define competitive differentiation in this dynamic sector.

11 items

1. Executive Summary

2. At-home Fertility Test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global At-home Fertility Test Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global At-home Fertility Test Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Offline Sales

6.1.2. Online Sales

6.2. Global At-home Fertility Test Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Men

6.2.2. Woman

6.3. Global At-home Fertility Test Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global At-home Fertility Test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global At-home Fertility Test Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global At-home Fertility Test Market Competition by Key Manufacturers

8.1. Global At-home Fertility Test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global At-home Fertility Test: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Modern Fertility

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. LetsGetChecked

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Everlywell

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ro.Co

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Legacy

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Mira

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Fellow Semen

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pregmate

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Stix Ovulation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Superdrug

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hertility

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SpermCheck

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. London Egg Bank

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Walgreens

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. SwimCount

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Orchid

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. ExSeed

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Bird&Be

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Kindbody

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. myLAB Box

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. YO Sperm Test

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Thorne

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Mojo

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Natalist

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Vitall

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Labcorp OnDemand

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Pride Angel

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Thriva

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. DAM Health Retail

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. DiagnoseAtHome

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global At-home Fertility Test Market

Figure 4: Global At-home Fertility Test Market: Drivers

Figure 5: Global At-home Fertility Test Market: Challenges

Figure 6: Global At-home Fertility Test Market: Trends

Figure 7: Global At-home Fertility Test Market: Opportunity

Figure 8: Global At-home Fertility Test Market: Restraint

Figure 9: Global At-home Fertility Test Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global At-home Fertility Test Market Value (USD Million) By Region

Figure 15: Global At-home Fertility Test Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global At-home Fertility Test Market Value (USD Million) By Region

Figure 23: Global At-home Fertility Test Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global At-home Fertility Test Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global At-home Fertility Test Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global At-home Fertility Test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global At-home Fertility Test Market Value (USD Million) By Region

Table 10: Global At-home Fertility Test Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global At-home Fertility Test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global At-home Fertility Test Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global At-home Fertility Test Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Modern Fertility Basic Information And Sales Area

Table 31: Modern Fertility. Products Portfolio

Table 32: LetsGetChecked Basic Information And Sales Area

Table 33: LetsGetChecked. Products Portfolio

Table 34: Everlywell Basic Information And Sales Area

Table 35: Everlywell. Products Portfolio

Table 36: Ro.Co Basic Information And Sales Area

Table 37: Ro.Co. Products Portfolio

Table 38: Legacy Basic Information And Sales Area

Table 39: Legacy. Products Portfolio

Table 40: Mira Basic Information And Sales Area

Table 41: Mira. Products Portfolio

Table 42: Fellow Semen Basic Information And Sales Area

Table 43: Fellow Semen. Products Portfolio

Table 44: Pregmate Basic Information And Sales Area

Table 45: Pregmate. Products Portfolio

Table 46: Stix Ovulation Basic Information And Sales Area

Table 47: Stix Ovulation. Products Portfolio

Table 48: Superdrug Basic Information And Sales Area

Table 49: Superdrug. Products Portfolio

Table 50: Hertility Basic Information And Sales Area

Table 51: Hertility. Products Portfolio

Table 52: SpermCheck Basic Information And Sales Area

Table 53: SpermCheck. Products Portfolio

Table 54: London Egg Bank Basic Information And Sales Area

Table 55: London Egg Bank. Products Portfolio

Table 56: Walgreens Basic Information And Sales Area

Table 57: Walgreens. Products Portfolio

Table 58: SwimCount Basic Information And Sales Area

Table 59: SwimCount. Products Portfolio

Table 60: Orchid Basic Information And Sales Area

Table 61: Orchid. Products Portfolio

Table 62: ExSeed Basic Information And Sales Area

Table 63: ExSeed. Products Portfolio

Table 64: Bird&Be Basic Information And Sales Area

Table 65: Bird&Be. Products Portfolio

Table 66: Kindbody Basic Information And Sales Area

Table 67: Kindbody. Products Portfolio

Table 68: myLAB Box Basic Information And Sales Area

Table 69: myLAB Box. Products Portfolio

Table 70: YO Sperm Test Basic Information And Sales Area

Table 71: YO Sperm Test. Products Portfolio

Table 72: Thorne Basic Information And Sales Area

Table 73: Thorne. Products Portfolio

Table 74: Mojo Basic Information And Sales Area

Table 75: Mojo. Products Portfolio

Table 76: Natalist Basic Information And Sales Area

Table 77: Natalist. Products Portfolio

Table 78: Vitall Basic Information And Sales Area

Table 79: Vitall. Products Portfolio

Table 80: Labcorp OnDemand Basic Information And Sales Area

Table 81: Labcorp OnDemand. Products Portfolio

Table 82: Pride Angel Basic Information And Sales Area

Table 83: Pride Angel. Products Portfolio

Table 84: Thriva Basic Information And Sales Area

Table 85: Thriva. Products Portfolio

Table 86: DAM Health Retail Basic Information And Sales Area

Table 87: DAM Health Retail. Products Portfolio

Table 88: DiagnoseAtHome Basic Information And Sales Area

Table 89: DiagnoseAtHome. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global At-home Fertility Test Market Value (USD Million) By Region

Table 95: Global At-home Fertility Test Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

At-home Fertility Test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Modern Fertility; LetsGetChecked; Everlywell; Ro.Co; Legacy; Mira; Fellow Semen; Pregmate; Stix Ovulation; Superdrug; Hertility; SpermCheck; London Egg Bank; Walgreens; SwimCount; Orchid; ExSeed; Bird&Be; Kindbody; myLAB Box; YO Sperm Test; Thorne; Mojo; Natalist; Vitall; Labcorp OnDemand; Pride Angel; Thriva; DAM Health Retail; DiagnoseAtHome
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options